Akero Therapeutics, Inc. (AKRO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
601 Gateway Boulevard
South San Francisco, CA 94080
United States of America (the)
Phone
650 487 6488
Website
Sector
Healthcare
Industry
Biotechnology
Employees
69
First IPO Date
June 20, 2019
| Name | Title | Pay | Year Born |
| Andrew Cheng | President, Chief Executive Officer & Director | 1.1M | 1967 |
| Scott A. Gangloff | Chief Technical Officer | 558,641 | 1974 |
| Jonathan Young | Co-Founder, Executive Vice President, Chief Operating Officer & Secretary | 710,500 | 1970 |
| Catriona Yale | Executive Vice President & Chief Development Officer | 716,300 | 1972 |
| Timothy Rolph | Co-Founder & Chief Scientific Officer | 722,315 | 1954 |
| William R. White | Executive Vice President, Chief Financial Officer, Treasurer & Head of Corporate Development | 739,500 | 1973 |
| John J. Schembri | Senior Vice President & Head of Finance | 0 | 1962 |
| Patrick Lamy | Senior Vice President of Commercial Strategy | 0 | 1973 |
| Thomas Ross | Senior Vice President & Head of Legal | 0 | N/A |
Akero Therapeutics, Inc. is a biopharmaceutical firm dedicated to addressing cardio-metabolic disorders, with a specific focus on nonalcoholic steatohepatitis (NASH). Its primary objective is the creation of therapeutic agents aimed at re-establishing metabolic equilibrium and enhancing overall well-being. The company's flagship investigational drug is efruxifermin (EFX), a synthetic analog of fibroblast growth factor 21. EFX is designed to shield cells from stress and modulate the systemic metabolism of fats, carbohydrates, and proteins throughout the body. This promising compound is currently undergoing evaluation in a Phase 2a clinical investigation, known as the BALANCED study, for individuals diagnosed with biopsy-confirmed NASH. Originally established as Pippin Pharmaceuticals, Inc., the organization rebranded as Akero Therapeutics, Inc. in May 2018. Founded in 2017, Akero Therapeutics maintains its corporate headquarters in South San Francisco, California.